Dupilumab 200mg/1.14ml solution for injection pre-filled disposable devices
NHS hospitals in England used £34,177,329 of indicative cost of Dupilumab 200mg/1.14ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 31.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dupilumab 200mg/1.14ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dupilumab 200mg/1.14ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £4,536,528 |
| Manchester University Nhs Ft | £3,431,014 |
| Oxford University Hospitals Nhs Ft | £2,960,475 |
| University Hospitals Plymouth Nhs Trust | £1,811,322 |
| Portsmouth Hospitals Nhs Trust | £1,693,055 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,481,186 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,393,909 |
| Somerset P/Ship Nhs Foundation Trust | £957,522 |
| Aintree University Hospital Nhs Ft | £851,271 |
| Nottingham University Hospitals Trust | £812,692 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.